Variantyx
PrivateLast Round
VC Round
Apr 26, 2024
Total Funding Raised
$94.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Variantyx is a biotechnology company that provides whole genome sequencing and analysis services for diagnosing rare inherited disorders, reproductive health, and precision oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Variantyx Comparables
Compare Variantyx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GeneDx Holdings Corp. | 83% | |
| 3billion, Inc. | 78% | |
| SIRION Biotech | 77% |
Variantyx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 26, 2024 | ||||
| Series C | Oct 18, 2023 | ||||
| Debt | Oct 18, 2022 | ||||
| Series C Extension | Feb 14, 2022 | ||||
| Series C | Mar 15, 2021 | ||||
Series B | Jun 6, 2019 |
Variantyx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kreos Capital | Debt |
| Bosch Ventures | VC Round, Series C, Series C Extension |
| New Era Capital Partners | VC Round, Series C, Series B, Series C Extension |
| Peregrine Ventures (California) | VC Round |
| Kreos Capital | Debt |
| IBM Ventures | Series C |
| GF Financial Markets (UK) Limited | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 51% MoM, reaching 11.3K.
- Oct 14, 2025
Launched proprietary Genomic Unity® testing platform for whole genome sequencing diagnostics.
Variantyx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Variantyx's valuation, stock price, and market status.
Is Variantyx a public or private company?
Variantyx is a private company.
What is the current stock price of Variantyx?
Variantyx is a private company with no public stock price. No recent secondary market data is available.
How much is Variantyx worth (valuation)?
Valuation information for Variantyx is not publicly available.
Can I buy Variantyx stock?
Variantyx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Variantyx's last funding round?
Variantyx's most recent funding round was VC Round on April 26, 2024.
Who are the main investors in Variantyx?
Key investors in Variantyx include Kreos Capital, New Era Capital Partners, GF Financial Markets (UK) Limited, ERA Capital, Pitango Venture Capital.
Will Variantyx IPO soon?
No public IPO plans have been announced for Variantyx.
How can I track Variantyx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Variantyx's secondary market activity and sign up for updates.